Can someone with laryngospasm receive the COVID-19 vaccine?

In general, whether patients with laryngospasm can receive the COVID-19 vaccine depends on their current medical condition. Patients whose condition is stable and who have had no episodes in the past six months may receive the vaccine after evaluation by a doctor. However, those experiencing an acute attack or frequent episodes are advised to postpone vaccination. Detailed analysis is as follows:

If a patient with laryngospasm has achieved long-term stability through standardized treatment, with no sudden spasms of the throat muscles or breathing difficulties in the past six months, and is otherwise in good health, they may receive the COVID-19 vaccine normally after disclosing their medical history and undergoing assessment by a physician.

If the laryngospasm is currently in an acute phase—characterized by obvious symptoms such as hoarseness, difficulty breathing, or noisy breathing (stridor)—or if episodes have been frequent within the past three months, this indicates that the condition is not yet under control. Vaccination during this period could potentially worsen existing symptoms due to the body's stress response.

Patients should strictly follow medical advice for treating laryngospasm and avoid triggers such as cold air and irritating odors. Before vaccination, it is essential to fully inform the doctor about the medical condition and any medications being taken. After receiving the vaccine, remain at the site for 30 minutes of observation, rest well upon returning home, and avoid excessive use of the voice.